Bank of Montreal’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-484,069
Closed -$5.31M – 4247
2023
Q4
$5.31M Sell
484,069
-326,381
-40% -$3.55M ﹤0.01% 1257
2023
Q3
$8.73M Sell
810,450
-106,008
-12% -$1.14M ﹤0.01% 1051
2023
Q2
$9.83M Buy
916,458
+105,961
+13% +$1.12M ﹤0.01% 1015
2023
Q1
$8.59M Buy
810,497
+660,497
+440% +$6.86M ﹤0.01% 997
2022
Q4
$1.54M Sell
150,000
-65,858
-31% -$668K ﹤0.01% 1920
2022
Q3
$2.17M Buy
+215,858
New +$2.16M ﹤0.01% 1768

Other funds holding RENE

Bank of Montreal's RENE Position: Q1 2024 in Review

Bank of Montreal sold out of Cartesian Growth Corp II (RENE) in Q1 2024, closing a stake of 484,069 shares — an estimated $5.31M sold.

Bank of Montreal first reported a position in RENE in Q3 2022 and held it in 6 quarters. The position peaked at $9.83M in Q2 2023. 33 funds tracked by Wall St. Rank hold RENE as of Q1 2024.

  • Bank of Montreal reported no remaining Cartesian Growth Corp II position as of Q1 2024 after selling out during the quarter.
  • Bank of Montreal sold 484,069 Cartesian Growth Corp II shares in Q1 2024, an estimated $5.31M.
  • Bank of Montreal first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 6 quarters.
  • Bank of Montreal's Cartesian Growth Corp II position peaked at $9.83M in Q2 2023.
  • 33 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q1 2024.

Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.